Wu, Z and Zhang, X and Xu, X and Chen, Y and Hu, T and Kang, Z and Li, S and Wang, H and Liu, W and Ma, X and Guan, M
(2014)
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Journal of Hematology and Oncology, 7 (1).
Abstract
Mutations in JAK2, MPL and CALR are highly relevant to the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms (MPNs). We performed high resolution melting analysis and Sanger sequencing together with T-A cloning to elucidate the unique mutation profile of these genes, in Chinese patients with MPNs. Peripheral blood DNA samples were obtained from 80 patients with polycythemia vera (PV), 80 patients with essential thrombocytosis (ET) and 50 patients with primary myelofibrosis (PMF). Ten PV patients were identified with diverse JAK2 exon 12 mutations. Five novel JAK2 Exon 12 mutation patterns (M532V/E543G, N533D, M535I/H538Y/K549I, E543G and D544N) were described. JAK2 V617F was detected in 140 samples (66 PV, 45 ET and 29 PMF). JAK2 Exon 12 mutations were prevalent (13%) and variable in the Chinese patients. Compared with PV patients with JAK2 V617F mutations, PV patients with JAK2 exon 12 mutations had an earlier median onset of disease (P = 0.0013). MPL W515L/K mutations were discerned in 4 ET and 3 PMF patients. Two kinds of CALR mutation, c. 1179-1230del and c. 1234-1235insTTGTC were detected in 20 ET and 16 PMF patients. A novel CALR mutation pattern (c. 1173-1223del/c. 1179-1230del) was identified in 2 PMF samples. In addition, 17 scattered point mutations in CALR c.1153 to c.1255 were also detected in 13 cases with CALR frame-shifting variations and 2 cases without CALR frame-shifting variations. Female patients showed a predisposition to CALR mutations (P = 0.0035). Chinese Ph-negative MPN patients have a unique mutation landscape in the common molecular markers of MPN diagnosis. Validation of the molecular diagnostic pipeline should be emphasized since there is a considerable ethnical diversity in the molecular profiles of Ph-negative MPNs. © 2014 Wu et al.; licensee BioMed Central Ltd.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID  |
---|
Wu, Z | | | | Zhang, X | | | | Xu, X | | | | Chen, Y | | | | Hu, T | | | | Kang, Z | | | | Li, S | | | | Wang, H | | | | Liu, W | | | | Ma, X | MXIAOCHA@pitt.edu | MXIAOCHA | | Guan, M | | | |
|
Date: |
15 July 2014 |
Date Type: |
Publication |
Journal or Publication Title: |
Journal of Hematology and Oncology |
Volume: |
7 |
Number: |
1 |
DOI or Unique Handle: |
10.1186/s13045-014-0048-6 |
Schools and Programs: |
School of Pharmacy > Pharmaceutical Sciences |
Refereed: |
Yes |
Date Deposited: |
21 Dec 2016 20:43 |
Last Modified: |
02 Feb 2019 16:58 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/29533 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |